Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AdaptHealth (AHCO) Interest Expenses (2019 - 2024)

AdaptHealth has reported Interest Expenses over the past 6 years, most recently at $31.4 million for Q3 2024.

  • Quarterly results put Interest Expenses at $31.4 million for Q3 2024, down 2.71% from a year ago — trailing twelve months through Jun 2025 was $31.4 million (down 76.06% YoY), and the annual figure for FY2023 was $130.3 million, up 19.09%.
  • Interest Expenses for Q3 2024 was $31.4 million at AdaptHealth, down from $33.0 million in the prior quarter.
  • Over the last five years, Interest Expenses for AHCO hit a ceiling of $33.5 million in Q4 2023 and a floor of $7.5 million in Q2 2020.
  • Median Interest Expenses over the past 5 years was $25.6 million (2021), compared with a mean of $24.9 million.
  • Peak annual rise in Interest Expenses hit 453.26% in 2020, while the deepest fall reached 48.88% in 2020.
  • AdaptHealth's Interest Expenses stood at $13.6 million in 2020, then soared by 88.26% to $25.6 million in 2021, then increased by 19.12% to $30.5 million in 2022, then increased by 9.76% to $33.5 million in 2023, then dropped by 6.14% to $31.4 million in 2024.
  • The last three reported values for Interest Expenses were $31.4 million (Q3 2024), $33.0 million (Q2 2024), and $32.5 million (Q1 2024) per Business Quant data.